{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:01:22Z","timestamp":1791460882212,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T00:00:00Z","timestamp":1543363200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803334"],"award-info":[{"award-number":["81803334"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Centre for Global Health and Medicine","award":["30A-1007"],"award-info":[{"award-number":["30A-1007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12879-018-3516-8","type":"journal-article","created":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T08:37:29Z","timestamp":1543394249000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["A mathematical model of biomedical interventions for HIV prevention among men who have sex with men in China"],"prefix":"10.1186","volume":"18","author":[{"given":"Jinghua","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6556-0995","authenticated-orcid":false,"given":"Stuart","family":"Gilmour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huachun","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuantao","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph Tak-fai","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,28]]},"reference":[{"key":"3516_CR1","volume-title":"World health organization: 2011 estimates for the HIV\/AIDS epidemic in China","author":"Ministry of Health of China","year":"2011","unstructured":"Ministry of Health of China. Joint Unitied nations Programme on HIV\/AIDS. In: World health organization: 2011 estimates for the HIV\/AIDS epidemic in China; 2011."},{"issue":"1","key":"3516_CR2","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1186\/s12879-016-1904-5","volume":"16","author":"S Tang","year":"2016","unstructured":"Tang S, Tang W, Meyers K, Chan P, Chen Z, Tucker JD. HIV epidemiology and responses among men who have sex with men and transgender individuals in China: a scoping review. BMC Infect Dis. 2016;16(1):588.","journal-title":"BMC Infect Dis"},{"issue":"11","key":"3516_CR3","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S1473-3099(13)70245-7","volume":"13","author":"L Zhang","year":"2013","unstructured":"Zhang L, Chow EPF, Jing J, Zhuang X, Li X, He M, Sun H, Li X, Gorgens M, Wilson D, et al. HIV prevalence in China: integration of surveillance data and a systematic review. Lancet Infect Dis. 2013;13(11):955\u201363.","journal-title":"Lancet Infect Dis"},{"key":"3516_CR4","volume-title":"2015 China AIDS response progress report","author":"National Health and Family Planning Commission of China","year":"2015","unstructured":"National Health and Family Planning Commission of China: 2015 China AIDS response progress report. 2015."},{"issue":"9562","key":"3516_CR5","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S0140-6736(07)60315-8","volume":"369","author":"Z Wu","year":"2007","unstructured":"Wu Z, Sullivan SG, Wang Y, Rotheram-Borus MJ, Detels R. Evolution of China's response to HIV\/AIDS. Lancet (London, England). 2007;369(9562):679\u201390.","journal-title":"Lancet (London, England)"},{"issue":"12","key":"3516_CR6","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1093\/infdis\/jix542","volume":"216","author":"Jillian Pintye","year":"2017","unstructured":"Pintye J, Baeten JM, Celum C, Mugo N, Ngure K, Were E, Bukusi E, John-Stewart G, Heffron RA. Maternal tenofovir disoproxil fumarate use during pregnancy is not associated with adverse perinatal outcomes among HIV-infected east African women: a prospective study. J Infect Dis. 2017;216(12):1561-568.","journal-title":"The Journal of Infectious Diseases"},{"issue":"12","key":"3516_CR7","first-page":"1187","volume":"20","author":"Z Wu","year":"2016","unstructured":"Wu Z. The progress and challenges of promoting HIV\/AIDS 90\u201390-90 strategies in China. The Chinese Journal of Disease Control and Prevention. 2016;20(12):1187\u20139.","journal-title":"The Chinese Journal of Disease Control and Prevention"},{"issue":"7","key":"3516_CR8","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s10461-012-0225-y","volume":"16","author":"H Zou","year":"2012","unstructured":"Zou H, Hu N, Xin Q, Beck J. HIV testing among men who have sex with men in China: a systematic review and meta-analysis. AIDS Behav. 2012;16(7):1717\u201328.","journal-title":"AIDS Behav"},{"issue":"4","key":"3516_CR9","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1097\/QAI.0b013e3181f3d3c1","volume":"55","author":"EP Chow","year":"2010","unstructured":"Chow EP, Wilson DP, Zhang L. The next era of HIV in China: rapidly spreading epidemics among men who have sex with men. J Acquir Immune Defic Syndr. 2010;55(4):e32\u20133 author reply e33\u201334.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"8","key":"3516_CR10","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1258\/ijsa.2012.011393","volume":"23","author":"YH Hsieh","year":"2012","unstructured":"Hsieh YH, Ruan Y, Chen CW, Shi W, Li D, Luo F, Shao Y. HIV prevalence and underreporting of men who have sex with men in Beijing. Int J STD AIDS. 2012;23(8):606\u20137.","journal-title":"Int J STD AIDS"},{"issue":"11","key":"3516_CR11","first-page":"945","volume":"49","author":"X Hu","year":"2015","unstructured":"Hu X, Chen F, Ding F, Lin X, Wang X, He H, Huang W, Yang Q, Zhang H. Coverage of HIV related follow-up intervention and antiretroviral treatment and its correlation among HIV-positive men who have sex with men of 3 cities in China. Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]. 2015;49(11):945\u20139.","journal-title":"Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]"},{"issue":"27","key":"3516_CR12","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","volume":"363","author":"RM Grant","year":"2010","unstructured":"Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, Goicochea P, Casapia M, Guanira-Carranza JV, Ramirez-Cardich ME, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587\u201399.","journal-title":"N Engl J Med"},{"issue":"23","key":"3516_CR13","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1056\/NEJMoa1506273","volume":"373","author":"JM Molina","year":"2015","unstructured":"Molina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, Tremblay C, Le Gall JM, Cua E, Pasquet A, et al. On-demand Preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med. 2015;373(23):2237\u201346.","journal-title":"N Engl J Med"},{"key":"3516_CR14","unstructured":"World Health Organization. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Geneva, Switzerland; 2015."},{"issue":"16","key":"3516_CR15","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1097\/QAD.0b013e3283574e54","volume":"26","author":"J Li","year":"2012","unstructured":"Li J, Gilmour S, Zhang H, Koyanagi A, Shibuya K. The epidemiological impact and cost-effectiveness of HIV testing, antiretroviral treatment and harm reduction programs. AIDS. 2012;26(16):2069\u201378.","journal-title":"AIDS"},{"issue":"12","key":"3516_CR16","doi-asserted-by":"publisher","first-page":"778","DOI":"10.7326\/0003-4819-153-12-201012210-00004","volume":"153","author":"EF Long","year":"2010","unstructured":"Long EF, Brandeau ML, Owens DK. The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States. Ann Intern Med. 2010;153(12):778\u201389.","journal-title":"Ann Intern Med"},{"issue":"9657","key":"3516_CR17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S0140-6736(08)61697-9","volume":"373","author":"RM Granich","year":"2009","unstructured":"Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet (London, England). 2009;373(9657):48\u201357.","journal-title":"Lancet (London, England)"},{"key":"3516_CR18","volume-title":"Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection","author":"Organization WH","year":"2013","unstructured":"Organization WH. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection. Geneva: Recommendations for a Public Health Approach; 2013."},{"issue":"1","key":"3516_CR19","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.4081\/idr.2011.e10","volume":"3","author":"L Zhang","year":"2011","unstructured":"Zhang L, Fung Chow EP, Wilson DP. Men who have sex with men in China have relatively low numbers of sexual partners. Infectious disease reports. 2011;3(1):e10.","journal-title":"Infectious disease reports"},{"issue":"8","key":"3516_CR20","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1093\/cid\/cir494","volume":"53","author":"S Lodi","year":"2011","unstructured":"Lodi S, Phillips A, Touloumi G, Geskus R, Meyer L, Thiebaut R, Pantazis N, Amo JD, Johnson AM, Babiker A, et al. Time from human immunodeficiency virus seroconversion to reaching CD4+ cell count thresholds <200, <350, and <500 cells\/mm(3): assessment of need following changes in treatment guidelines. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2011;53(8):817\u201325.","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"},{"issue":"9","key":"3516_CR21","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMoa1600693","volume":"375","author":"MS Cohen","year":"2016","unstructured":"Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, et al. Antiretroviral therapy for the prevention of HIV-1 transmission. N Engl J Med. 2016;375(9):830\u20139.","journal-title":"N Engl J Med"},{"issue":"2","key":"3516_CR22","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1001\/jama.2016.5148","volume":"316","author":"AJ Rodger","year":"2016","unstructured":"Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, van Lunzen J, Corbelli GM, Estrada V, Geretti AM, Beloukas A, et al. Sexual activity without condoms and risk of HIV transmission in Serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy. Jama. 2016;316(2):171\u201381.","journal-title":"Jama"},{"issue":"11","key":"3516_CR23","first-page":"1186","volume":"33","author":"F Gao","year":"2012","unstructured":"Gao F, Zhong X, Peng B, Zhang Y, Liang H, Zou Y, Dai J, Liu Q, Song B, Huang W, et al. Pre-exposure prophylaxis for HIV high-risk groups: an analysis of clinical compliance. Acad J Second Mil Univ. 2012;33(11):1186\u201393.","journal-title":"Acad J Second Mil Univ"},{"issue":"22","key":"3516_CR24","first-page":"2469","volume":"35","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Zhong X, Peng B, Huang W, Huang A. Cohort retention and predictors in HIV pre-exposure prophylaxis clinical trial among men who have sex with men. Journal of Third Military Medical University. 2013;35(22):2469\u201372.","journal-title":"Journal of Third Military Medical University"},{"key":"3516_CR25","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9781139013567","volume-title":"Regression analysis of count data, second edition. Edn. Cambridge","author":"AC Cameron","year":"2013","unstructured":"Cameron AC, Trivedi PK. Regression analysis of count data, second edition. Edn. Cambridge. New York, NY: Cambridge University Press; 2013."},{"key":"3516_CR26","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780195108248.001.0001","volume-title":"Cost-effectiveness in health and medicine","author":"MR Gold","year":"1996","unstructured":"Gold MR. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996."},{"issue":"2","key":"3516_CR27","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1016\/S2352-3018(15)00056-9","volume":"3","author":"N Punyacharoensin","year":"2016","unstructured":"Punyacharoensin N, Edmunds WJ, De Angelis D, Delpech V, Hart G, Elford J, Brown A, Gill ON, White RG. Effect of pre-exposure prophylaxis and combination HIV prevention for men who have sex with men in the UK: a mathematical modelling study. Lancet HIV. 2016;3(2):e94\u2013e104.","journal-title":"Lancet HIV"},{"issue":"14","key":"3516_CR28","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1097\/QAD.0000000000000767","volume":"29","author":"AN Phillips","year":"2015","unstructured":"Phillips AN, Cambiano V, Miners A, Lampe FC, Rodger A, Nakagawa F, Brown A, Gill ON, De Angelis D, Elford J, et al. Potential impact on HIV incidence of higher HIV testing rates and earlier antiretroviral therapy initiation in MSM. Aids. 2015;29(14):1855\u201362.","journal-title":"Aids"},{"issue":"8","key":"3516_CR29","doi-asserted-by":"publisher","first-page":"541","DOI":"10.7326\/0003-4819-156-8-201204170-00001","volume":"156","author":"JL Juusola","year":"2012","unstructured":"Juusola JL, Brandeau ML, Owens DK, Bendavid E. The cost-effectiveness of preexposure prophylaxis for HIV prevention in the United States in men who have sex with men. Ann Intern Med. 2012;156(8):541\u201350.","journal-title":"Ann Intern Med"},{"issue":"12","key":"3516_CR30","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/S1473-3099(16)30311-5","volume":"16","author":"BE Nichols","year":"2016","unstructured":"Nichols BE, Boucher CA, van der Valk M, Rijnders BJ, van de Vijver DA. Cost-effectiveness analysis of pre-exposure prophylaxis for HIV-1 prevention in the Netherlands: a mathematical modelling study. Lancet Infect Dis. 2016;16(12):1423\u20139.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"3516_CR31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S1473-3099(17)30540-6","volume":"18","author":"V Cambiano","year":"2018","unstructured":"Cambiano V, Miners A, Dunn D, McCormack S, Ong KJ, Gill ON, Nardone A, Desai M, Field N, Hart G, et al. Cost-effectiveness of pre-exposure prophylaxis for HIV prevention in men who have sex with men in the UK: a modelling study and health economic evaluation. Lancet Infect Dis. 2018;18(1):85\u201394.","journal-title":"Lancet Infect Dis"},{"key":"3516_CR32","doi-asserted-by":"publisher","unstructured":"Zhang L, Peng P, Wu Y, Ma X, Soe NN, Huang X, Wu H, Markowitz M, Meyers K. Modelling the epidemiological impact and cost-effectiveness of PrEP for HIV transmission in MSM in China. AIDS Behav. 2018. https:\/\/doi.org\/10.1007\/s10461-018-2205-3 .","DOI":"10.1007\/s10461-018-2205-3"},{"issue":"9835","key":"3516_CR33","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1016\/S0140-6736(11)61852-7","volume":"379","author":"AD Kashuba","year":"2012","unstructured":"Kashuba AD, Patterson KB, Dumond JB, Cohen MS. Pre-exposure prophylaxis for HIV prevention: how to predict success. Lancet (London, England). 2012;379(9835):2409\u201311.","journal-title":"Lancet (London, England)"},{"key":"3516_CR34","doi-asserted-by":"crossref","unstructured":"Traeger MW, Schroeder SE, Wright EJ, Hellard ME, Cornelisse VJ, Doyle JS, Stoove MA. Effects of pre-exposure prophylaxis for the prevention of HIV infection on sexual risk behavior in men who have sex with men: a systematic review and meta-analysis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2018.","DOI":"10.1093\/cid\/ciy182"},{"issue":"3","key":"3516_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032329","volume":"7","author":"F Zhou","year":"2012","unstructured":"Zhou F, Gao L, Li S, Li D, Zhang L, Fan W, Yang X, Yu M, Xiao D, Yan L, et al. Willingness to accept HIV pre-exposure prophylaxis among Chinese men who have sex with men. PLoS One. 2012;7(3):e32329.","journal-title":"PLoS One"},{"issue":"6","key":"3516_CR36","doi-asserted-by":"publisher","first-page":"e0129300","DOI":"10.1371\/journal.pone.0129300","volume":"10","author":"H Lin","year":"2015","unstructured":"Lin H, Ding Y, Liu X, Wu Q, Shen W, He N. High prevalence of HIV infection and bisexual networks among a sample of men who have sex with men in eastern China. PLoS One. 2015;10(6):e0129300.","journal-title":"PLoS One"},{"issue":"3","key":"3516_CR37","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1089\/apc.2012.0412","volume":"27","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Peng B, She Y, Liang H, Peng HB, Qian HZ, Vermund SH, Zhong XN, Huang A. Attitudes toward HIV pre-exposure prophylaxis among men who have sex with men in western China. AIDS Patient Care STDs. 2013;27(3):137\u201341.","journal-title":"AIDS Patient Care STDs"},{"key":"3516_CR38","volume-title":"Cost per DALY averted thresholds for low- and middle-income countries: evidence from cross country data. Working Papers","author":"J Ochalek","year":"2015","unstructured":"Ochalek J, Lomas J, Claxton K. Cost per DALY averted thresholds for low- and middle-income countries: evidence from cross country data. Working Papers; 2015."},{"issue":"8","key":"3516_CR39","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.jval.2016.02.017","volume":"19","author":"B Woods","year":"2016","unstructured":"Woods B, Revill P, Sculpher M, Claxton K. Country-level cost-effectiveness thresholds: initial estimates and the need for further research. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2016;19(8):929\u201335.","journal-title":"Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research"},{"key":"3516_CR40","volume-title":"Making choices in health","author":"World Health Organization","year":"2003","unstructured":"World Health Organization. Making choices in health. Geneva: WHO guide to cost-effective- ness analysis; 2003."},{"key":"3516_CR41","volume-title":"Macro- economics and health","author":"WHO Commission on Macroeconomics and Health","year":"2001","unstructured":"WHO Commission on Macroeconomics and Health. Macro- economics and health. Geneva, Switzerland: investing in health for economic development; 2001."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3516-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-018-3516-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3516-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T06:33:52Z","timestamp":1775284432000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-018-3516-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,28]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3516"],"URL":"https:\/\/doi.org\/10.1186\/s12879-018-3516-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,28]]},"assertion":[{"value":"13 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable, as this was a mathematical model.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"600"}}